Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
93.05 CHF | -0.12% | +0.35% | +9.51% |
08:07am | NOVARTIS AG : Berenberg remains Neutral | ZD |
06:01am | Novartis' Cosentyx Receives Canadian Approval for Hidradenitis Suppurativa Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.51% | 208B | |
+37.98% | 723B | |
+34.08% | 595B | |
-2.87% | 369B | |
+20.30% | 332B | |
+2.65% | 282B | |
+16.96% | 244B | |
-4.70% | 205B | |
+0.80% | 168B | |
+7.59% | 166B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Says Sandoz's Prolia, Xgeva Biosimilar Accepted for Review in US